Quality Assurance

Quality Risk Assessment New Product Introduction: Non-Sterile Ointment / Semi-Solid Product

by

Quality Risk Assessment – New Product Introduction: Non-Sterile Ointment / Semi-Solid Product Objective: Identify, assess, and control quality risks associated with the development and manufacture of a new non-sterile ointment/semi-solid pharmaceutical product. 1️⃣ Formulation Risks API–excipient incompatibility API solubility & dispersion Particle size / agglomeration Homogeneity of formulation Physical/chemical instability Preservative effectiveness, where applicable 2️⃣ Manufacturing … Read more

Quality Risk Assessment New Product Introduction: Non-Sterile Soft Gelatin Capsules

by

Quality Risk Assessment – New Product Introduction: Non-Sterile Soft Gelatin Capsules Objective: Identify, assess, and control quality risks before commercial manufacture of a new soft gelatin capsule product. 1. Formulation Risks API–excipient incompatibility API degradation / oxidation / hydrolysis Fill viscosity and uniformity Solubility and precipitation Over/under-fill risk 2. Gelatin Shell Risks Gelatin–fill interaction Shell thickness … Read more

Quality Risk Evaluation for New Product Introduction Non-Sterile Oral Liquid Dosage Forms

by

Quality Risk Assessment for Solid Oral Dosage Forms for New Product Introduction OBJECTIVEEvaluate and control quality risks before introducing a new oral liquid product to ensure patient safety, product quality, process robustness, and GMP compliance. KEY RISK AREAS 1️⃣ Product & Formulation API–excipient compatibility Solubility / suspension characteristics CQAs: assay, pH, viscosity, microbial limits Preservative … Read more

Quality Risk Evaluation for New Product Introduction Non-Sterile Solid Oral Dosage Forms

by

Quality Risk Assessment for Solid Oral Dosage Forms Non-Sterile Solid Oral Dosage Forms 🎯 OBJECTIVEEvaluate and control quality risks before introducing a new solid oral dosage product to ensure patient safety, product quality, GMP compliance, and process robustness. 🔍 KEY RISK AREAS 1️⃣ Product & Formulation API/excipient compatibility CQAs: assay, dissolution, content uniformity, impurities API … Read more

Quality Risk Evaluation for New Product Introduction in a Sterile Facility

by

Quality Risk Assessment for New Sterile Product Introduction Objective: Evaluate and control risks before introducing a new sterile product to ensure patient safety, sterility assurance, product quality, and GMP compliance. Key Risk Areas Product & Process Formulation compatibility Critical Quality Attributes (CQAs) Critical Process Parameters (CPPs) Aseptic processing requirements Terminal sterilization feasibility Facility & Utilities … Read more

Sticky Notes for Pharmaceutical QMS (Quality Management System)

by

Sticky Notes for Pharmaceutical QMS (Quality Management System) Practical sticky notes for a pharmaceutical Quality Assurance (QA) department. You can print them or display them near workstations, laboratories, production areas, and document-control desks. 1. Daily QMS Reminders NOTE 1 — GMP Compliance “DO IT RIGHT. DOCUMENT IT RIGHT.” Follow approved SOPs. Never bypass an approved … Read more

QUALITY ASSURANCE & GMP REGULATORY SUPPORT

by

QUALITY ASSURANCE & GMP REGULATORY SUPPORT “Strengthen Your Quality System. Be Audit-Ready. Stay GMP Compliant” AASP Lifesciences Pvt. Ltd. offers professional part-time Quality Assurance and GMP regulatory support to pharmaceutical and healthcare manufacturing organizations seeking experienced QA assistance without the need for a full-time resource. 🔹 OUR QA & GMP SUPPORT SERVICES ✅ GMP Audit … Read more

CAPA Effectiveness in the Pharma Industry

by

CAPA Effectiveness in the Pharma Industry Repeated Environmental Monitoring Excursions Scenario: During routine environmental monitoring of a Grade C manufacturing area, repeated excursions in microbial counts are observed at a specific monitoring location. Initial Observation – Over three months: Multiple microbial excursions occurred at the same location. Initial investigations focused primarily on cleaning and operator practices. … Read more

Pharmaceutical Change HVAC and Environmental Control

by

Pharmaceutical Change Control: GMP Process, Risk Assessment & Implementation Pharmaceutical Change: HVAC and Environmental Control 1. Proposed Pharmaceutical Change: Replace and upgrade an existing HVAC system serving a Grade C manufacturing area to improve temperature, relative humidity, pressure differential, air-change performance, and overall environmental control. Reason for This Pharmaceutical Change: The existing HVAC system is … Read more

Quality by Design (QbD)

by

Quality by Design (QbD) Framework for tablet manufacturing, covering Critical Quality Attributes (CQAs), Critical Process Parameters (CPPs), their relationship, and a practical risk assessment. 1. Tablet Manufacturing – Critical Quality Attributes (CQAs) CQAs are physical, chemical, microbiological, or performance characteristics that must remain within an appropriate limit/range to ensure the finished tablet meets its intended … Read more